{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"InMode Ltd. "},"Symbol":{"label":"Symbol","value":"INMD"},"Address":{"label":"Address","value":"TAVOR BUILDING, SHA'AR YOKNEAM,P.O. BOX 533, YOKNEAM, 2069206, Israel"},"Phone":{"label":"Phone","value":"+972 49096313"},"Industry":{"label":"Industry","value":"Biotechnology: Electromedical & Electrotherapeutic Apparatus"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"Middle East"},"CompanyDescription":{"label":"Company Description","value":"InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its products platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, Evolve, Evoke, and Morpheus8. The majority of its revenue comes from the United States."},"CompanyUrl":{"label":"Company Url","value":"https://www.inmodemd.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Michael Kreindel","title":"Chief Technology Officer & Director"},{"name":"Moshe Mizrahy","title":"Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}